Cynthia M. Butitta
2009
In 2009, Cynthia M. Butitta earned a total compensation of $657.8K as Chief Operating Officer and Chief Financial Officer at MabVax Therapeutics Holdings, a 22% decrease compared to previous year.
Compensation breakdown
| Option Awards | $278,778 |
|---|---|
| Salary | $379,000 |
| Total | $657,778 |
Butitta received $379K in salary, accounting for 58% of the total pay in 2009.
Butitta also received $278.8K in option awards.
Rankings
In 2009, Cynthia M. Butitta's compensation ranked 5,901st out of 9,885 executives tracked by ExecPay. In other words, Butitta earned more than 40.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,901 out of 9,885 | 40th |
Division Manufacturing | 2,126 out of 3,690 | 42nd |
Major group Chemicals And Allied Products | 451 out of 866 | 48th |
Industry group Drugs | 296 out of 638 | 54th |
Industry Pharmaceutical Preparations | 219 out of 446 | 51st |
Source: SEC filing on April 7, 2010.
Butitta's colleagues
We found four more compensation records of executives who worked with Cynthia M. Butitta at MabVax Therapeutics Holdings in 2009.
2009
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2009
Marc Steuer
MabVax Therapeutics Holdings
Senior Vice President, Business Development
2009
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2009
Stefan Ryser
MabVax Therapeutics Holdings